Partner Content Partner Content Explore the future of ocular gene editing and strategic drug... Ophthalmic Drugs Conference
Partner Content Partner Content SMi’s Europe’s Leading Ophthalmic Conference is only 3 weeks... Europe's Leading Ophthalmic Conference
Partner Content Partner Content SMi’s Ophthalmic Drugs Conference is only 4 weeks away! Only 4 Weeks Remain for Ophthalmic Drugs
Partner Content Partner Content Spotlight on Key Sessions at Ophthalmic Drugs this November Sessions at Ophthalmic Drugs
Partner Content Partner Content Exceptional speaker line-up for Ophthalmic Drugs Hear from Santen, Novaliq GmBh, Aptar Pharma and more
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
